Contributor Page
Ropes & Gray LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 5969000
Fax: +1 212 5969090
1211 Avenue of the Americas
New York
NY 10036-8704
United States
By Scott A. McKeown
PTAB Designates Two Older Decisions as Precedential, Updates Hearing Rooms/Notices
By Ropes & Gray LLP's Corporate Governance & Compliance Practice
On September 6, 2019, the SEC's Division of Corporation Finance announced a change to how it will handle company requests to exclude a shareholder's proposal from a company's proxy materials.
By Ryan Rohlfsen, Elizabeth Noonan-Pomada, Andrew Kaplan
A bill introduced in the House of Representatives in late July would allow the United States to prosecute foreign officials who take bribes. The "Foreign Extortion Prevention Act" ("FEPA"), introduced by two Democratic and two Republican
By Gregory Levine, Kellie Combs
Tune in to this discussion to learn more about the expedited review programs and how to secure the benefits.
By Amy Roy, Robert Skinner
They discuss the key arguments raised in the trial over the claims, and the evidence relied upon by the court in finding in MetWest's favor across the board.
By Scott A. McKeown
As discussed last month, as PTAB proceedings conclude at the Federal Circuit and return to the district courts
By Scott A. McKeown
The Patent Trial and Appeal Board (PTAB) will host a Boardside Chat webinar today, from noon to 1pm (EST). Vice Chief Judge Scott Weidenfeller,
By Scott A. McKeown
With June's flurry of Senate hearings on the subject of patentable subject matter (i.e., 35 U.S.C. § 101),
By Katherine Wang
After almost two years of extensive review and deliberation, the Chinese legislature finally passed the new Drug Administration Law ("DAL") on August 26, 2019, which will go into effect on December 1, 2019.
By Ropes & Gray LLP's Investment Management Practice Group
On August 21, 2019, the SEC published two releases: Commission Guidance Regarding Proxy Voting Responsibilities of Investment Advisers (the "IA Release") and Commission
By Mimi Yang, David Chen, Karen Oddo, Yujin Liu
Third parties serve a critical function to multinational life sciences companies ("MNCs") internationally. MNCs rely on third parties for various functions
By Scott A. McKeown
As we move into the fall season, a host of bar association programs are on the horizon from IPO, AIPLA and others. But first, a few options for PTAB focused CLE
By Melissa C. Bender, Isabel K.R. Dische, Keith Higgins, Joshua A. Lichtenstein, Michael Littenberg
On August 19, 2019, the Business Roundtable (BRT) released a new Statement on the Purpose of a Corporation (the Statement), superseding previous BRT statements and outlining a modern
By Data Practice Group
Failure to establish reasonable safeguards would mean potential action against the company by New York regulators.
By Scott A. McKeown
Earlier this year the Patent Trial & Appeal Board (PTAB) instituted trial in Sling TV, L.L.C. et al. v. Realtime Adaptive Streaming, LLC, IPR2018-01331
Contributor's Topics